Prevalence and drug use correlates of inadvertent fentanyl exposure among individuals misusing drugs in seven U.S. states

References

• Drug Enforcement Administration. 2023. DEA.gov/resources/facts-about fentanyl.
   Google Scholar
• Ahmad FB, Cisewski JA, Rossen LM, et al. 2023. Provisional drug overdose death counts. National Center for Health Statistics. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm?source=email#ref7.
   Google Scholar
• Tsai B. 2023. Fentanyl overdose death rates more than tripled from 2016 to 2021. National Center for Health Statistics. https://blogs.cdc.gov/nchs/2023/05/03/7338/.
   Google Scholar
• Palamar JJ, Cottler LB, Goldberger BA, et al. Trends in characteristics of fentanyl-related poisonings in the United States, 2015-2021. Am J Drug Alcohol Abuse. 2022;48(4):471–480. doi:10.1080/00952990.2022.2081923.
   PubMed Web of Science ®Google Scholar
• Twillman RK, Dawson E, LaRue L, et al. Evaluation of trends of near-real-time urine drug test results for methamphetamine, cocaine, heroin, and fentanyl. JAMA Netw Open. 2020;3(1):e1918514. doi:10.1001/jamanetworkopen.2019.18514.
   PubMed Web of Science ®Google Scholar
• Diversion Control Division. 2022. National Forensic Laboratory Information System: NFLIS-2021 Annual Report U.S. Department of Justice, U.S. Drug Enforcement Administration.
   Google Scholar
• Kerensky T, LaRochelle M, Fan SL, et al. Non-prescription Fentanyl Positive Toxicology: prevalence, Positive Predictive Value of Fentanyl Immunoassay Screening, and Description of Co-substance Use. J Addict Med. 2021;15(2):150–154. doi:10.1097/ADM.0000000000000723.
   PubMed Web of Science ®Google Scholar
• Martinez S, Jones JD, Brandt L, et al. The Increasing Prevalence of Fentanyl: a Urinalysis-Based Study Among Individuals With Opioid Use Disorder in New York City. Am J Addict. 2021;30(1):65–71. doi:10.1111/ajad.13092.
   PubMed Web of Science ®Google Scholar
• Drug Enforcement Administration. 2023. Fentanyl awareness. https://www.dea.gov/fentanylawareness.
   Google Scholar
• Friedman J, Godvin M, Molina C, et al. Fentanyl, heroin, and methamphetamine-based counterfeit pills sold at tourist-oriented pharmacies in Mexico: an ethnographic and drug checking study. Drug Alcohol Depend. 2023;249:110819. doi:10.1016/j.drugalcdep.2023.110819.
   PubMed Web of Science ®Google Scholar
• Griswold MK, Chai PR, Krotulski AJ, et al. Self-identification of nonpharmaceutical fentanyl exposure following heroin overdose. Clin Toxicol (Phila)). 2018;56(1):37–42. doi:10.1080/15563650.2017.1339889.
   PubMed Web of Science ®Google Scholar
• Mitra S, Boyd J, Wood E, et al. Elevated prevalence of self-reported unintentional exposure to fentanyl among women who use drugs in a Canadian setting: a cross-sectional analysis. Int J Drug Policy. 2020;83:102864. doi:10.1016/j.drugpo.2020.102864.
   PubMed Web of Science ®Google Scholar
• Lorvick J, Hemberg J, George M, et al. Just another thing for me to stress off of: Responses to unintentional fentanyl use in a community-based study of people who use opioids. Res Sq. 2023;rs.3.rs-2842551. doi:10.21203/rs.3.rs-2842551/v1.
   PubMedGoogle Scholar
• McKnight C, Weng CA, Reynoso M, et al. Understanding intentionality of fentanyl use and drug overdose risk: findings from a mixed methods study of people who inject drugs in New York City. Int J Drug Policy. 2023;118:104063. doi:10.1016/j.drugpo.2023.104063.
   PubMed Web of Science ®Google Scholar
• Cance JD, Adams ET, D'Amico EJ, et al. Leveraging the Full Continuum of Care to Prevent Opioid Use Disorder. Prev Sci. 2023;24(Suppl 1):30–39. doi:10.1007/s11121-023-01545-x.
   PubMed Web of Science ®Google Scholar
• Tilhou AS, Birstler J, Baltes A, et al. Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin. Harm Reduct J. 2022;19(1):142. doi:10.1186/s12954-022-00720-7.
   PubMed Web of Science ®Google Scholar
• Quest Diagnostics. 2023. Drug Misuse in America, 2022. https://filecache.mediaroom.com/mr5mr_questdiagnostics/203680/Quest%20Diagnostics%20Health%20Trends%20DM%20Report%202022_12.8.22.pdf.
   Google Scholar
• Palamar JJ. Awareness that cocaine can contain fentanyl among nightclub and festival attendees in New York City, 2018-2022. Public Health Nurs. 2023;40(4):566–571. doi:10.1111/phn.13193.
   PubMed Web of Science ®Google Scholar
• Shin SS, LaForge K, Stack E, et al. It wasn’t here, and now it is. It’s everywhere": fentanyl’s rising presence in Oregon’s drug supply. Harm Reduct J. 2022;19(1):76. doi:10.1186/s12954-022-00659-9.
   PubMed Web of Science ®Google Scholar
• Daniulaityte R, Ruhter L, Juhascik M, et al. Attitudes and experiences with fentanyl contamination of methamphetamine: exploring self-reports and urine toxicology among persons who use methamphetamine and other drugs. Harm Reduct J. 2023;20(1):54. doi:10.1186/s12954-023-00782-1.
   PubMed Web of Science ®Google Scholar
• Peiper NC, Clarke SD, Vincent LB, et al. Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States. Int J Drug Policy. 2019;63:122–128. doi:10.1016/j.drugpo.2018.08.007.
   PubMed Web of Science ®Google Scholar
• Reed MK, Guth A, Salcedo VJ, et al. You can’t go wrong being safe: motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs. Int J Drug Policy. 2022;103:103643. doi:10.1016/j.drugpo.2022.103643.
   PubMed Web of Science ®Google Scholar
• Sherman SG, Morales KB, Park JN, et al. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. Int J Drug Policy. 2019;68:46–53. doi:10.1016/j.drugpo.2019.03.003.
   PubMed Web of Science ®Google Scholar
• Crocombe RA, Giuntini G, Schiering DW, et al. Field-portable detection of fentanyl and its analogs: a review. J Forensic Sci. 2023;68(5):1570–1600. doi:10.1111/1556-4029.15355.
   PubMed Web of Science ®Google Scholar
• Grace Rose C, Kulbokas V, Carkovic E, et al. Contextual factors affecting the implementation of drug checking for harm reduction: a scoping literature review from a North American perspective. Harm Reduct J. 2023;20(1):124. doi:10.1186/s12954-023-00856-0.
   PubMed Web of Science ®Google Scholar
• Stewart RE, Cardamone NC, Loscalzo E, et al. There’s absolutely no downside to this, I mean, except community opposition: a qualitative study of the acceptability of vending machines for harm reduction. Harm Reduct J. 2023;20(1):25. doi:10.1186/s12954-023-00747-4.
   PubMed Web of Science ®Google Scholar
• Arendt D. Expanding the accessibility of harm reduction services in the United States: measuring the impact of an automated harm reduction dispensing machine. J Am Pharm Assoc. 2023;63(1):309–316. 2023 Jan-Feb doi:10.1016/j.japh.2022.10.027.
   Google Scholar
• Freiermuth CE, Ancona RM, Brown JL, et al. Evaluation of a large-scale health department naloxone distribution program: per capita naloxone distribution and overdose morality. PLoS One. 2023;18(8):e0289959. doi:10.1371/journal.pone.0289959.
   PubMed Web of Science ®Google Scholar
• Lemen PM, Garrett DP, Thompson E, et al. High-dose naloxone formulations are not as essential as we thought. medRxiv. 2023:2023.08.07.23293781. doi:10.1101/2023.08.07.23293781.
   PubMedGoogle Scholar
• Sellen K, Markowitz B, Parsons JA, et al. Considerations for the design of overdose education and naloxone distribution interventions: results of a multi-stakeholder workshop. BMC Public Health. 2023;23(1):888. doi:10.1186/s12889-023-15554-6.
   PubMed Web of Science ®Google Scholar
• Marshall T, Viste D, Jones S, et al. Beliefs, attitudes and experiences of virtual overdose monitoring services from the perspectives of people who use substances in Canada: a qualitative study. Harm Reduct J. 2023;20(1):80. doi:10.1186/s12954-023-00807-9.
   PubMed Web of Science ®Google Scholar
• Safi F, Rioux W, Rider N, et al. Feasibility and acceptability of inserts promoting virtual overdose monitoring services (VOMS) in naloxone kits: a qualitative study. Harm Reduct J. 2023;20(1):64. doi:10.1186/s12954-023-00792-z.
   PubMed Web of Science ®Google Scholar
• Lohman L. 2023. U.S. regions history and importance; [cited 2023, November 27]. Available from https://study.com/academy/lesson/what-are-the-regions-of-the-united-states.html.
   Google Scholar
• Rosenblum A, Parrino M, Schnoll SH, et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend. 2007;90(1):64–71. doi:10.1016/j.drugalcdep.2007.02.012.
   PubMed Web of Science ®Google Scholar
• Immunalysis 2023. https://immunalysis.com/products/oral-fluid/quantisal/.
   Google Scholar
• Rosano TG, Wood M, Hooten WM, et al. Application and clinical value of definitive drug monitoring in pain management and addiction medicine. Pain Med. 2022;23(4):821–833. doi:10.1093/pm/pnab303.
   PubMed Web of Science ®Google Scholar
• Magura S, Lee-Easton MJ, Abu-Obaid R, Reed P, Allgaier B, Amaratunga P, Lorenz-Lemberg B, Levitas M, Achtyes ED. Comparing presumptive with direct-to-definitive drug testing in oral fluid vs. urine for a U.S. national sample of individuals misusing drugs. Drug Alcohol Depend. 2023;250(1):1–9. doi:10.106/j.drugalcdep.2023.110894.
   Web of Science ®Google Scholar
• Arup Laboratories 2023. https://www.aruplab.com/files/resources/pain-management/DrugAnalytesPlasmaUrine.pdf.
   Google Scholar
• SPSS Version 29. https://www.ibm.com/docs/en/spss-statistics/29.0.0. Accessed Jan. 6, 2024.
   Google Scholar
• von Euler M, Villén T, Svensson JO, et al. Interpretation of the presence of 6-monoacetylmorphine in the absence of morphine-3-glucuronide in urine samples: evidence of heroin abuse. Ther Drug Monit. 2003;25(5):645–648. doi:10.1097/00007691-200310000-00015.
   PubMed Web of Science ®Google Scholar
• Kreek MJ, Vocci FJ. History and current status of opioid maintenance treatments: blending conference session. J Subst Abuse Treat. 2002;23(2):93–105. doi:10.1016/s0740-5472(02)00259-3.
   PubMed Web of Science ®Google Scholar
• Addiction Center 2023. https://www.addictioncenter.com/drugs/heroin/speedball/.
   Google Scholar
• Hunt DE, Lipton DS, Goldsmith D, et al. Street pharmacology: uses of cocaine and heroin in the treatment of addiction. Drug Alcohol Depend. 1984;13(4):375–387. doi:10.1016/0376-8716(84)90005-x.
   PubMed Web of Science ®Google Scholar
• Drug Enforcement Administration Diversion Control Division. 2023. Fentanyl. https://www.deadiversion.usdoj.gov/drug_chem_info/fentanyl.pdf#search=fentanyl.
   Google Scholar
• Drug Enforcement Administration Diversion Control Division. 2023. Methamphetamine. https://www.deadiversion.usdoj.gov/drug_chem_info/meth.pdf#search=methamphetamine.
   Google Scholar
• Ciccarone D, Ondocsin J, Mars SG. Heroin uncertainties: exploring users’ perceptions of fentanyl-adulterated and -substituted ‘heroin’. Int J Drug Policy. 2017;46:146–155. doi:10.1016/j.drugpo.2017.06.004.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 2021. https://www.cdc.gov/nchs/pressroom/sosmap/drug_poisoning_mortality/drug_poisoning.htm.
   Google Scholar
• Mattson CL, Tanz LJ, Quinn K, et al. Trends and geographic patterns in drug and synthetic opioid overdose deaths—United States, 2013–2019. MMWR Morb Mortal Wkly Rep. 2023;70(6):202–207. doi:10.15585/MMWR.MM7006A4.
   Web of Science ®Google Scholar
• Shulman M, Wai JM, Nunes EV. Buprenorphine treatment for opioid use disorder: an overview. CNS Drugs. 2019;33(6):567–580. doi:10.1007/s40263-019-00637-z.
   PubMed Web of Science ®Google Scholar